Gsk Share Discussion Threads

[sicker] 10/4/2015 08:31

I'm with nik, although I may be lucky enough to have a portfolio value high enough to be fee free. It is costly in my experience to sell paper compared to a small commission on line. You also get to vote and I should imagine that if I did want to attend an AGM, that could be arranged.

[darias] 10/4/2015 08:31

Zeppo

I think it depends on how many shares in a company you hold.

If, as I suspect, you only hold a minor percentage of shares in a company, say less than 1% then holding paper shares is a waste of time, money and effort. The advantages of a nominee account are too great to be ignored. You can still go to agms etc by asking your nominee to provide you with the appropriate authorisation.

If you hold over 1% of a company's shares then I think that you are an important shareholder and have a major influence on that company's policies which you should exercise and be more active than just going to an agm.

You should also consider your age and health status. If you are young and in good health then go for a nominee. If you are not young and in poor health your heirs might find that a nominee account is more difficult for getting hold of the assets in the event of your death. I have no experience of this problem.

[nik rosa] 10/4/2015 08:12

Zeppo - I find Nominee holding really convenient and don't mind paying the quarterly fee for the service they provide. I still have total control over my holdings/dealings. Hope this helps.
NR

[zeppo] 09/4/2015 22:20

Divis into account. I am under pressure not to get certification of new shares.

Do we have to give up and accept nominee holdings?

Certification allows divis to be paid direct and gives us voting rights and AGM invites etc. as a right.

Should I stick out for paper?

Moral blackmail that I might have difficulty selling paper shares in the future is being applied.

Advice please.

Z

[jadeticl3] 09/4/2015 21:50

Yes, now that we have this Q4 divi banked can someone remind me what we know for certain about the handout of cash/shares from the Novartis surplus, please?

[philanderer] 09/4/2015 13:17

Nice dividend just received into the account :-)

[philanderer] 08/4/2015 23:23

Missed this while I was away..

"GSK to establish global vaccines R&D centre in Rockville, US"

[jadeticl3] 08/4/2015 21:39

Don't forget that D Bank had a buy recommendation for GSK at £19-60 prior to their more recent £13-00, so they show a commendable willingness to admit they are not always right, not in so many words though.

[philanderer] 08/4/2015 12:49

Money for old rope Phil ;-)

[philo124] 08/4/2015 09:00

Well, that was rocket science. What's their target for Greek war reparations?

[philanderer] 08/4/2015 08:50

Deutsche Bank boosted their price target on shares of GlaxoSmithKline plc (LON:GSK) from GBX 1300p to 1600p in a research note issued on Wednesday. The firm currently has a “hold” rating on the stock.

[tradermichael] 06/4/2015 08:28

That looks like creative reporting to me. The article may be confusing revenue lost by erosion of market share (incl. patent expiries) and pressures on price in the US, but that's nothing new, particularly in the respiratory market.

Anyway, I'm happy to re-invest my 23p/share dividend on Thursday.

(next xd is about 19p/share in about a month's time)

[jadeticl3] 05/4/2015 17:07

An interesting article to be sure, but what of the comment that " a slate of new product approvals that failed to live up to revenue expectations".

I know that this article addresses the problem for staff in the rationalisation of the vaccine business, but the quotation given above is news to me. Is it true? Has this been released by GSK?

[tradermichael] 05/4/2015 12:20

GlaxoSmithKline ($GSK) is setting up a global vaccines hub in Rockville, MD, in the wake of its big asset swap with Novartis ($NVS). And the move will force hundreds of staffers in Cambridge, MA, and Philadelphia to either look for a relocation package or exit the company.

Rumors about GlaxoSmithKline's plans for vaccines have been circulating in the Cambridge area for weeks now. In mid-March GSK told FierceBiotech that no final decisions had been made about its vaccines sites, but mid-day today a spokesperson confirmed that the group's future lies in Rockville.

The pharma giant says it will now have three global vaccines R&D centers, "complementing the company's existing global R&D centres in Rixensart, Belgium, and in Siena, Italy, a site which GSK recently acquired from Novartis in March 2015."

[jadeticl3] 02/4/2015 14:36

Tournesol, I'm not sure that I agree with you on this point!

[tournesol] 02/4/2015 10:34

Buywell2

"Passer pour un idiot aux yeux d'un imbécile est une volupté de fin gourmet."
(Georges COURTELINE)

Et c'est meme plus delicieux quand cet imbécile est un enfant qui se plaint contre les adultes plus sages que lui-meme.

[woodhawk] 01/4/2015 11:59

At the moment I'm very glad I bought heavily at the lows yesterday, cyberian.

[cyberian] 01/4/2015 11:10

Maybe a few more tax driven sells today and tomorrow by PI's and then switch into ISA or Sipp, but for other trades the 30 day rule applies, so further sells should be fairly limited. The large Institutions would already have made their move/position, and there could be a squeeze higher next Tuesday. The last week saw some significant good size trades at well above 1600p. I was somewhat surprised by the level of activity and subsequent falls yesterday...if any room with ISA then good to add, or switch from any other holding that may have run its course. However, that assumes one holds GSK as a better longer term hold/return, and of course the reverse could be true!!!. With GSK one has the divi return which is very attractive to many investors and there remains some good upside with possibility of a spin-off of a division, greater efficiencies in production, more balanced/focussed work force, and the net Novartis return to shareholders. Pity we have the uncertainty of the share price next Tuesday if one wants to add more GSK with the extra £15,000 plus ISA allowance for next tax year...maybe best to wait a few days to see how the share price settles down. Any chance of a Labour victory or messy hung parliament may have a severe drag on the Pound£ which would be OK for us, I guess.

[madengland] 01/4/2015 08:33

Yes thanks, I am planning to buy back in Isa and Sipp.

[woodhawk] 01/4/2015 08:04

You need to wait 30 days before you buy back in, if you want to book a capital gain - otherwise doesn't count.

[madengland] 01/4/2015 07:59

Must admit having had some nice gains over the last few weeks I thought it rude not to book in my capital gains limit for the year so I sold. Intending to buy back in. It's miraculously worked well for me, by luck as oppose to judgement.

[woodhawk] 31/3/2015 14:27

Agreed cyberian, so I've been buying today - only 2 trading days left this tax year.

[jadeticl3] 31/3/2015 14:16

Alphorn, it could get worse than that. You may have to produce a book of encyclopaedic proportions to cover all possible side effects depending on which mix of drugs you take. You would need to start reading this a month before you are ill.